Healthcare companies harness AI to navigate supply chain challenges

New research by Economist Impact and supported by DP World reveals that 46% of companies in the healthcare sector are using Artificial Intelligence (AI) to identify and address potential disruptions in their supply chains, underscoring the industry’s commitment to adaptability and resilience.

FDA approves import of French drug for syphilis amidst wider drug shortages – Pharmaceutical Technology

Share this article Pfizer’s anti-infective is one of the many drugs in shortage. The FDA expects the shortage to recover in Q2 2024. Credits: WESTOCK

January 11, 2024

Roche unruffled by China bill as it looks to grow roots in the region

Roche on Wednesday morning said it has “minor exposure” from the Biosecure Act, adding that it is making strides in China’s pharma and diagnostics markets.

April 25, 2024

Vaxart reports mixed PhII data for norovirus vaccine; J&J to proceed with Cidara influenza deal

Vaxart announced on Wednesday that a Phase II study of its oral norovirus vaccine achieved the primary endpoint of reducing the rate of infection. The

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.